Meagan E. Deming

2.1k total citations
16 papers, 595 citations indexed

About

Meagan E. Deming is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Meagan E. Deming has authored 16 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Epidemiology and 2 papers in Health. Recurrent topics in Meagan E. Deming's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and Respiratory viral infections research (4 papers). Meagan E. Deming is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (5 papers) and Respiratory viral infections research (4 papers). Meagan E. Deming collaborates with scholars based in United States, Switzerland and Belgium. Meagan E. Deming's co-authors include Ralph S. Baric, Meagan Bolles, Allison L. Totura, Martin T. Ferris, Mark T. Heise, Sudhakar Agnihothram, Kristin A. Long, Alan C. Whitmore, Lisa E. Gralinski and W. D. Funkhouser and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Meagan E. Deming

15 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meagan E. Deming United States 9 486 108 97 90 74 16 595
Alejandra Barreto Ecuador 5 416 0.9× 51 0.5× 55 0.6× 86 1.0× 83 1.1× 7 571
Bethany Girard United States 9 590 1.2× 120 1.1× 84 0.9× 111 1.2× 120 1.6× 24 694
Anne Cossmann Germany 12 795 1.6× 92 0.9× 48 0.5× 88 1.0× 76 1.0× 27 912
Mimi M. Hou United Kingdom 2 706 1.5× 67 0.6× 63 0.6× 103 1.1× 277 3.7× 6 824
John C. Prostko United States 8 481 1.0× 67 0.6× 34 0.4× 61 0.7× 65 0.9× 20 540
Carina C. D. Joe United Kingdom 5 728 1.5× 69 0.6× 82 0.8× 120 1.3× 280 3.8× 9 878
Susan M Rattigan United States 5 681 1.4× 40 0.4× 64 0.7× 50 0.6× 57 0.8× 13 789
Udo Goetsch Germany 11 501 1.0× 34 0.3× 143 1.5× 53 0.6× 29 0.4× 20 591
Sirapa Klinfueng Thailand 15 349 0.7× 62 0.6× 349 3.6× 47 0.5× 88 1.2× 42 660
Julia E. Tubert United States 10 517 1.1× 64 0.6× 64 0.7× 43 0.5× 199 2.7× 18 590

Countries citing papers authored by Meagan E. Deming

Since Specialization
Citations

This map shows the geographic impact of Meagan E. Deming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meagan E. Deming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meagan E. Deming more than expected).

Fields of papers citing papers by Meagan E. Deming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meagan E. Deming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meagan E. Deming. The network helps show where Meagan E. Deming may publish in the future.

Co-authorship network of co-authors of Meagan E. Deming

This figure shows the co-authorship network connecting the top 25 collaborators of Meagan E. Deming. A scholar is included among the top collaborators of Meagan E. Deming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meagan E. Deming. Meagan E. Deming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Deming, Meagan E., Elizabeth R. Brown, Monica A. McArthur, et al.. (2025). Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial. The Lancet Microbe. 6(4). 100984–100984. 2 indexed citations
2.
Atmar, Robert L., Getahun Abate, Meagan E. Deming, et al.. (2025). Emerging and Pandemic Pathogens: Lessons Learned From a Clinical Research Network. Clinical Infectious Diseases. 81(Supplement_2). S89–S102. 1 indexed citations
3.
Sajadi, Mohammad M., James Logue, Saman Saadat, et al.. (2022). Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection. mSphere. 7(6). e0027922–e0027922. 3 indexed citations
4.
O’Hara, Nathan N., John G Williams, Julia F. Slejko, et al.. (2021). Population Decline in COPD Admissions During the COVID-19 Pandemic Associated with Lower Burden of Community Respiratory Viral Infections. The American Journal of Medicine. 134(10). 1252–1259.e3. 31 indexed citations
5.
Deming, Meagan E., Déborah Goudiaby, Ousmane M. Diop, et al.. (2020). Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial. Vaccine. 38(47). 7526–7532. 1 indexed citations
6.
Edelman, Robert, Meagan E. Deming, Franklin R. Toapanta, et al.. (2020). The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route. Immunity & Ageing. 17(1). 9–9. 16 indexed citations
7.
Deming, Meagan E., Maarten F. Jebbink, Raymond J. Pickles, et al.. (2020). Culturing the Unculturable: Human Coronavirus HKU1 Infects, Replicates, and Produces Progeny Virions in Human Ciliated Airway Epithelial Cell Cultures. UNC Libraries. 6 indexed citations
8.
Deming, Meagan E., Nelson L. Michael, Merlin L. Robb, Myron S. Cohen, & Kathleen M. Neuzil. (2020). Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models. New England Journal of Medicine. 383(10). e63–e63. 67 indexed citations
9.
Deming, Meagan E. & Wilbur H. Chen. (2020). COVID-19 and Lessons to Be Learned from Prior Coronavirus Outbreaks. Annals of the American Thoracic Society. 17(7). 790–794. 9 indexed citations
10.
11.
Deming, Meagan E., Shyam Kottilil, & Eleanor Wilson. (2020). 1057. CpG-adjuvanted Hepatitis B vaccination improves seroprotection rates in Veterans with HIV. Open Forum Infectious Diseases. 7(Supplement_1). S558–S558. 2 indexed citations
12.
13.
Deming, Meagan E., et al.. (2019). Cognitive biases and knowledge deficits leading to delayed recognition of cryptococcal meningitis. IDCases. 18. e00588–e00588. 13 indexed citations
14.
Graham, Rachel L., Damon Deming, Meagan E. Deming, Boyd L. Yount, & Ralph S. Baric. (2018). Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform. Communications Biology. 1(1). 179–179. 43 indexed citations
15.
Sui, Jianhua, Meagan E. Deming, Barry Rockx, et al.. (2014). Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness. Journal of Virology. 88(23). 13769–13780. 49 indexed citations
16.
Bolles, Meagan, Meagan E. Deming, Kristin A. Long, et al.. (2011). A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge. Journal of Virology. 85(23). 12201–12215. 335 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandra Barreto Breakdown of academic impact, for papers by Bethany Girard Breakdown of academic impact, for papers by Anne Cossmann Breakdown of academic impact, for papers by Mimi M. Hou Breakdown of academic impact, for papers by John C. Prostko Breakdown of academic impact, for papers by Carina C. D. Joe Breakdown of academic impact, for papers by Susan M Rattigan Breakdown of academic impact, for papers by Udo Goetsch Breakdown of academic impact, for papers by Sirapa Klinfueng Breakdown of academic impact, for papers by Julia E. Tubert
Rankless by CCL
2026